The Evidence Base Post 18 November 2026 From rare disease breakthroughs to AI-enabled development: DIA–MHRA Global Summit Day 2 Laura Dormer Register with The Evidence Base for free to access this content Already have an account? Sign in By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.